All News
Filter News
Found 806,114 articles
-
Aridis Pharmaceuticals Announces 2018 Fourth Quarter and Year-End Financial Results and Business Update
3/28/2019
The Company, which is utilizing its proprietary MabIgX® antibody discovery platform to develop novel therapies for hospital acquired infections made considerable clinical development advances with its lead monoclonal antibody programs, AR-301 and AR-105, along with its cystic fibrosis (CF) candidate AR-501, an inhalable therapy to treat chronic lung infections impacting CF patients.
-
Cost-Effective Chiral Resolution Methods by BOC Sciences to Obtain High Purity Compounds
3/28/2019
BOC Sciences, a business of BOCSCI Inc., has announced to launch its chiral solution service in this late March, in an active response to the increasing demands of its global clients for chirally pure APIs
-
Agilent to Host National Academy of Engineering Business Meeting and Bioengineering Symposium
3/28/2019
Agilent Technologies Inc. (NYSE: A) today announced that it will host the western regional conference of the National Academy of Engineering, along with a technical symposium—Bioengineering, Advancing Our World—at company headquarters in Santa Clara, California, on March 28, 2019.
-
Improving Healthcare, Life & Specialty Ventures Partners with Harvard
3/28/2019
Life & Specialty Ventures, LLC (LSV), an ancillary insurance carrier headquartered in Little Rock, Ark., helped establish the Initiative to Integrate Oral Health and Medicine sponsored by the Harvard School of Dental Medicine.
-
Quadriga Partners advised Onyx M.D. on its sale to Health Carousel
3/28/2019
Represents another successful healthcare advisory transaction for Quadriga Partners
-
Novel First-In-Class FLIP Inhibitors for the Treatment of Cancer
3/28/2019
Queen’s University Belfast and Domainex are pleased to announce that their joint project team has successfully identified novel first-in-class small molecule inhibitors of the anti-apoptotic protein FLIP.
-
MCNA Dental Begins Florida Medicaid Contract
3/28/2019
MCNA Dental has begun administration of dental benefits for the Florida Medicaid Dental Health Program, serving Medicaid members and Individuals with Intellectual Disabilities statewide
-
ACT-IAC Announces Igniting Innovation 2019 Conference and Awards Finalists
3/28/2019
The American Council for Technology and Industry Advisory Council (ACT-IAC), the premier public-private partnership in the government IT community, today announced the top 40 finalists for the Sixth Annual Igniting Innovation 2019 Conference and Awards event.
-
Oxford Immunotec Announces New Initiative to Bring the Benefit of Modern Tuberculosis Testing to the Russian Federation
3/28/2019
Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today announced a new local production initiative to bring the benefits of the T-SPOT®.TB test to the Russian Federation.
-
Albizu University, Miami Dade's only Clinical Psy.D. university, now welcomes Argosy University students
3/28/2019
Albizu University has been added by the American Psychological Association to the list of accredited institutions accepting former Argosy University students who were pursing Clinical Psy.D. degrees.
-
American Society of Cannabis Medicine Joins Legislative Leaders on Capitol Hill. Focusing on the Future of Medical Cannabis.
3/28/2019
The American Society of Cannabis Medicine (ASCM) continued a national dialog by bringing stakeholders together at the Capitol Hill Club for more in-depth discussions to guide a national legislative strategy for the future of cannabis medicine and its significant impact on United States healthcare.
-
Veracyte Announces Participation in the 18th Annual Needham Healthcare Conference
3/28/2019
A replay of the webcast will be available for 90 days following the conclusion of the live presentation broadcast.
-
Five Extraordinary Women Will Be Honored In New York At The T.J. Martell Foundation 7th Annual Women Of Influence Awards
3/28/2019
The T.J. Martell Foundation for Cancer Research has announced the 2019 Women of Influence Awards which will be held Friday, May 10, 2019 at The Plaza Hotel, Grand Ballroom located at 768 5th Avenue in New York
-
Pharmacy Employers Cite Safety Benefits of Employing PTCB-Certified Compounded Sterile Preparation Technicians (CSPTs™)
3/28/2019
The Pharmacy Technician Certification Board (PTCB), the nation's leading certifying body for pharmacy technicians, announces that after administering over 800 Compounded Sterile Preparation Technician™ (CSPT™) Exams,
-
NantHealth Reports 2018 Fourth-Quarter, Full-Year Financial Results
3/28/2019
Total Revenue in Q4 was $22.9 Million
-
Foundation Fighting Blindness Announces Staffing Changes to Enhance Strategic Direction
3/28/2019
The Foundation Fighting Blindness, the world's leading non-government funder of cutting-edge retinal disease research, has made several changes and additions to its departments and staff to enhance the Foundation's strong engagement and relationships with all stakeholders.
-
Housing Works Announces Honorees For Annual Groundbreaker Awards
3/28/2019
Housing Works announced today their 2019 Groundbreaker Award honorees and chairs.
-
Velicept Therapeutics Announces Positive Top-Line Phase 2b Results for Solabegron in the Treatment of Overactive Bladder (OAB)
3/28/2019
Velicept Therapeutics, a privately-held specialty pharmaceutical company dedicated to the development of best-in-class compounds for the treatment of urological and gastrointestinal disorders, announced that its next generation beta-3 adrenoceptor agonist solabegron met the primary endpoint in VEL-2002, a Phase 2b study in patients with overactive bladder (OAB).
-
Biocept Reports 2018 Fourth Quarter and Full Year Financial Results
3/28/2019
Progress made implementing the Company's commercial strategy highlighted by 7% sequential quarterly growth in billable test volume in the fourth quarter of 2018 compared to the third quarter of 2018
-
Michael Levitt, PhD, a Recipient of the Nobel Prize in Chemistry, Appointed to the Scientific Advisory Board of Akelos Inc., Biotechnology Company Developing Opioid Drug Alternatives
3/28/2019
Akelos Inc., a biotechnology company currently developing and commercializing a novel, non-opioid anti-hyperalgesic drug to treat chronic and neuropathic pain, adds Michael Levitt, Ph.D., of Stanford University , to its roster of high-profile advisors.